Ma et al., 2007 - Google Patents
Effect of mid‐late mouse fetus' microenvironment on the growth of tumor cells after intrauterine transplantationMa et al., 2007
- Document ID
- 2535845557614157438
- Author
- Ma F
- Zhou L
- Fang L
- Bai J
- Zhao J
- Wang Y
- Wang Z
- Publication year
- Publication venue
- Cell biology international
External Links
Snippet
Successful intrauterine transplantation (IUT) of stem cells for treatment of fetal defects in some animal models of human diseases has prompted us to study the mechanisms of transplantation, immunological tolerance and embryonic environment. The objective of this …
- 210000004881 tumor cells 0 title abstract description 43
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/04—Cells produced using nuclear transfer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7519660B2 (en) | Genetically modified cells, tissues, and organs for treating disease | |
| Holm et al. | Embryo viability, duration of gestation and birth weight in sheep after transfer of in vitro matured and in vitro fertilized zygotes cultured in vitro or in vivo | |
| Pierce et al. | Yolk sac tumors of the testis | |
| JP2021126129A (en) | Genetically modified cells, tissues and organs for treating diseases | |
| Du et al. | Stem cells and reproduction | |
| JP2002511732A (en) | Compositions and methods for generating transgenic animals | |
| ES2547953T3 (en) | Compositions comprising female germ stem cells and methods of use thereof | |
| Beerheide et al. | Downregulation of β2-microglobulin in human cord blood somatic stem cells after transplantation into livers of SCID-mice: an escape mechanism of stem cells? | |
| Ozakpinar et al. | Ovarian stem cells: From basic to clinical applications | |
| JP2022043344A (en) | Methods relating to pluripotent cells | |
| Miah et al. | Ptpn11 deletion in CD4+ cells does not affect T cell development and functions but causes cartilage tumors in a T cell-independent manner | |
| JP5817955B2 (en) | Production of hemophilia A model pig | |
| Renaud | Strategies for investigating hemochorial placentation | |
| CN109136273B (en) | Method for preparing immunodeficient rat and application thereof | |
| US20110052545A1 (en) | Regeneration system, its production and use | |
| Ma et al. | Effect of mid‐late mouse fetus' microenvironment on the growth of tumor cells after intrauterine transplantation | |
| Campos-Junior et al. | Ovarian grafts 10 days after xenotransplantation: folliculogenesis and recovery of viable oocytes | |
| KR20070113754A (en) | Transgenic pig expressing daf gene to inhibit hyperacute rejection occurred by complement cascade and method thereof | |
| WO2016208532A1 (en) | Method for producing blood chimeric animal | |
| US20070124826A1 (en) | Method of differentiation from embryo-stem cell of primate to hematogenous cell | |
| JP5771240B2 (en) | Immunodeficient pig | |
| WO2001060984A1 (en) | Immortalized vascular adventitial cell line | |
| Nagaya et al. | Generation of insulin-like growth factor 1 receptor-knockout pigs as a potential system for interspecies organogenesis | |
| KR101147409B1 (en) | A transgenic porcine clonal somatic cell line expressing human FasL protein to inhibit cellular immunity and transgenic clone pig using the same | |
| JP5858908B2 (en) | Kit and method for preparing cynomolgus monkey MHC whole gene homozygote |